Events

Conference: Quantum Europe 2025
OCT
Wed
01
09:00 - 17:00

Starts in 2 months from now

Location

Brussels

Programmes
Digital, Industry & Space

Forum Europe is re-organising their Quantum Europe Conference this year. 

This year's conference will explore the EU's expanding quantum agenda, including initiatives such as the Quantum Flagship, EuroQCI, EU Quantum Strategy and forthcoming EU Quantum Act. Topics will also cover the impact of quantum technologies on cybersecurity, future communications, industrial adoption, and the ongoing tension between international cooperation and technological sovereignty.

This is a paid event!

You can find more information here and register here.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.